Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001206386-03-000003
Filing Date
2003-09-10
Accepted
2003-09-10 19:47:54
Documents
2
Period of Report
2003-09-09

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgardoc.html 4  
1 PRIMARY DOCUMENT edgardoc.xml 4 5863
3 EDGAR SUPPORTING DOCUMENT poa-marsh.txt EX-24 3121
  Complete submission text file 0001206386-03-000003.txt   10762
Mailing Address 320 WAKARA WAY SALT LAKE CITY UT 84108
Business Address 320 WAKARA WAY SALT LAKE CITY UT 84108
MYRIAD GENETICS INC (Issuer) CIK: 0000899923 (see all company filings)

EIN.: 870494517 | State of Incorp.: DE | Fiscal Year End: 0630
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 320 WAKARA WAY SALT LAKE CITY UT 84108
Business Address
MARSH RICHARD M (Reporting) CIK: 0001206386 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-26642 | Film No.: 03890796